The role of white matter abnormalities in treatment-resistant depression: A systematic review

Current Pharmaceutical Design

Volumn 21, Issue 10, 2015, Pages 1337-1346

  Serafini, Gianluca ^a   Pompili, Maurizio ^b   Borgwardt, Stefan ^c   Giuffra, Enrico ^a   Howes, Oliver ^d   Girardi, Paolo ^b   Amore, Mario ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF BASEL   (Switzerland)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Major depressive disorder; Neuroimaging; Pathogenesis; Treatment resistant depression; White matter lesions

Indexed keywords

BRAIN SIZE; CEREBELLUM; CORPUS CALLOSUM; DEFAULT MODE NETWORK; DISEASE ASSOCIATION; FRACTIONAL ANISOTROPY; HUMAN; MAJOR DEPRESSION; MIDDLE FRONTAL GYRUS; NEUROIMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESISTANT DEPRESSION; UNCUS; WHITE MATTER ABNORMALITY; WHITE MATTER LESION; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; PATHOLOGY; PHYSIOLOGY; PROCEDURES; WHITE MATTER;

CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; HUMANS; NEUROIMAGING; WHITE MATTER;

EID: 84926360712     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140929094531     Document Type: Review

References (89)

1. Langlieb AM, Guico-Pabia CJ. Beyond symptomatic improvement: assessing real-world outcomes in patients with major depressive disorder. Prim Care Companion J Clin Psychiatry 2010; 12: 1-12.
2. Soleimani L, Lapidus KA, Iosifescu DV. Diagnosis and treatment of major depressive disorder. Neurol Clin 2011; 29: 177-9.
3. Greer TL, Kurian BT, Trivedi MH. Defining and measuring functional recovery from depression. CNS Drugs 2010; 24: 267-84.
4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-57.
5. Pompili M, Iliceto P, Luciano D, et al. Higher hopelessness and suicide risk predict lower self-deception among psychiatric patients and non-clinical individuals. Riv Psichiatr 2011; 46: 24-30.
6. Serafini G, Pompili M, Innamorati M, Dwivedi Y, Brahmachari G, Girardi P. Pharmacological properties of glutamatergic drugs targeting NMDA receptors and their application in major depression. Curr Pharm Des 2013; 19: 1898-922.
7. Serafini G, Pompili M, Innamorati M, et al. The role of microRNAs in synaptic plasticity, major affective disorders and suicidal behavior. Neurosci Res 2012; 73: 179-90.
8. Serafini G, Pompili M, Innamorati M, et al. Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders. J Affect Disord 2011; 129: 47-55.
9. Petersen T, Gordon JA, Kant A, Fava M, Rosenbaum JF, Nierenberg AA. Treatment resistant depression and axis i co-morbidity. Psychol Med 2001; 31: 1223-39.
10. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905-17.
11. Holtzheimer PE, Mayberg HS. Stuck in a rut: rethinking depression and its treatment. Trends Neurosci 2011; 34: 1-9.
12. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002; 63: 963-71.
13. Fagiolini A, Kupfer DJ. Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry 2003; 53: 640-8.
14. Serafini G, Pompili M, Innamorati M, et al. Deep white matter hyperintensities as possible predictor of poor prognosis in a sample of patients with late-onset bipolar II disorder. Bipolar Disord 2010; 12: 755-6.
15. Pompili M, Innamorati M, Mann JJ, et al. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Progr Neuropsychopharmacol Biol Psychiatry 2008; 32: 1501-7.
16. Thomas AJ, Perry R, Barber R, Kalaria RR, O'brien JT. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann NY Acad Sci 2002a; 977: 333-9.
17. Thomas AJ, O'brien JT, Davis S, et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 2002b; 59: 785-92.
18. Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 2000; 48: 791-800.
19. Patankar T, Widjaja E, Chant H, et al. Relationship of deep whitematter hyperintensities and cerebral blood flow in severe carotid artery stenosis. Eur J Neurol 2006; 13: 10-6.
20. Koton S, Schwammenthal Y, Merzeliak O, et al. Cerebral leukoaraiosis in patients with stroke or TIA: Clinical correlates and 1-year outcome. Eur J Neurol 2009; 16: 218-25.
21. Manolio TA, Burke GL, O’Leary DH, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol 1999; 19: 356-65.
22. de Leeuw FE, de Groot JC, Bots ML, et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol 2000; 247: 291-6.
23. Gitelman DR, Klein-Gitelman MS, Ying J, et al. Brain morphometric changes associated with childhood-onset systemic lupus erythematosus and neurocognitive deficit. Arthritis Rheum. 2013; 65: 2190-200.
24. Kobayashi S, Okada K, Yamashita K. Incidence of silent lacunar lesion in normal adults and its relation to cerebral blood flow and risk factors. Stroke 1991; 22: 1379-83.
25. Aronson S. Intracranial vascular lesions in patients with diabetes mellitus. J Neuropathol Exp Neurol 1973; 32: 183-96.
26. Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease. Biol Psychiatry 1999; 46: 1595-602.
27. Charness ME. Brain lesions in alcoholics. Alcohol Clin Exp Res 1993; 17: 2-11.
28. Hao Y, Liu Z, Jiang T, et al. White matter integrity of the whole brain is disrupted in first-episode schizophrenia. Neuroreport 2006; 17: 23-6.
29. Kyriakopoulos M, Vyas NS, Barker GJ, Chitnis XA, Frangou S. A diffusion tensor imaging study of white matter in early-onset schizophrenia. Biol Psychiatry 2008; 63: 519-23.
30. Ma N, Li L, Shu N, et al. White matter abnormalities in firstepisode, treatment-naive young adults with major depressive disorder. Am J Psychiatry 2007; 164: 823-6.
31. Newcombe VF, Williams GB, Nortje J, et al. Analysis of acute traumatic axonal injury using diffusion tensor imaging. Br J Neurosurgery 2007; 21: 340-8.
32. Szeszko PR, Ardekani BA, Ashtari M, et al. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry 2005; 162: 602-5.
33. Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO. Frontal white matter microstructure and treatment response of latelife depression: a preliminary study. Am J Psychiatry 2002; 159: 1929-32.
34. Bae JN, Macfall JR, Krishnan KR, Payne ME, Steffens DC, Taylor WD. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol Psychiatry 2006; 60: 1356-63.
35. Li L, Ma N, Li Z, et al. Prefrontal white matter abnormalities in young adult with major depressive disorder: a diffusion tensor imaging study. Brain Res 2007; 1168: 124-8.
36. Beaulieu C, Allen PS. Determinants of anisotropic water diffusion in nerves. Magn Reson Med 1994; 31: 394-400.
37. Sneed JR, Culang-Reinlieb ME, Brickman AM, et al. MRI signal hyperintensities and failure to remit following antidepressant treatment. J Affect Disord 2011; 135: 315-20.
38. Jia Z, Huang X, Wu Q, et al. High-field magnetic resonance imaging of suicidality in patients with major depressive disorder. Am J Psychiatry 2010; 167: 1381-90.
39. Konarski JZ, McIntyre RS, Soczynska JK, Bottas A, Kennedy SH. Clinical translation of neuroimaging research in mood disorders. Psychiatry (Edgmont) 2006; 3: 46-57.
40. Lui S, Wu Q, Qiu L, et al. Resting-state functional connectivity in treatment-resistant depression. Am J Psychiatry 2011; 168: 642-8.
41. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. The Prisma statement for reporting systematic reviews and metaanalyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2535.
42. Peng HJ, Zheng HR, Ning YP, et al. Abnormalities of corticallimbic-cerebellar white matter networks may contribute to treatment-resistant depression: a diffusion tensor imaging study. BMC Psychiatry 2013; 13: 72.
43. de Diego-Adeliño J, Pires P, Gómez-Ansón B, et al. Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychol Med 2013: 1-12.
44. Guo WB, Liu F, Chen JD, et al. Altered white matter integrity of forebrain in treatment-resistant depression: a diffusion tensor imaging study with tract-based spatial statistics. Progr Neuropsychopharmacol Biol Psychiatry 2012; 38: 201-6.
45. Liu F, Guo W, Yu D, et al. Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans. Plos One 2012; 7: e40968.
46. Phillips JL, Batten LA, Aldosary F, Tremblay P, Blier P. Brainvolume increase with sustained remission in patients with treatment-resistant unipolar depression. J Clin Psychiatry 2012; 73: 625-31.
47. Hoogenboom WS, Perlis RH, Smoller JW, et al. Limbic system white matter microstructure and long-term treatment outcome in major depressive disorder: A diffusion tensor imaging study using legacy data. World J Biol Psychiatry 2014; 15: 122-34.
48. Peng J, Liu J, Nie B, et al. Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: a voxel-based morphometry study. Eur J Radiol 2011; 80: 395-9.
49. Patankar TF, Baldwin R, Mitra D, et al. Virchow-robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression. J Affect Disord 2007; 97: 265-70.
50. Broadway JM, Holtzheimer PE, Hilimire MR, et al. Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. Neuropsychopharmacology 2012; 37: 1764-72.
51. Guo W, Liu F, Xue Z, et al. Abnormal resting-state cerebellar-cerebral functional connectivity in treatment-resistant depression and treatment sensitive depression. Progr Neuropsychopharmacol Biol Psychiatry 2013; 44: 51-7.
52. Zanetti MV, Cordeiro Q, Busatto GF. Late onset bipolar disorder associated with white matter hyperintensities: a pathophysiological hypothesis. Progr Neuropsychopharmacol Biol Psychiatry 2007; 31: 551-6.
53. Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 2012; 69: 150-8.
54. Johansen-Berg H, Gutman DA, Behrens TE, et al. Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex 2008; 18: 1374-83.
55. Mayberg HS. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 2009; 119: 717-25.
56. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry 1997; 9: 471-81.
57. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002; 53: 545-74.
58. Hasler G, Northoff G. Discovering imaging endophenotypes for major depression. Mol Psychiatry 2011; 16: 604-19.
59. Price JL, Drevets WC. Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci 2012; 16: 61-71.
60. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010; 35: 192-216.
61. Gutman DA, Holtzheimer PE, Behrens TEJ, Johansen-Berg H, Mayberg HS. A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry 2009; 65: 276-82.
62. Sexton CE, Mackay CE, Ebmeier KP. A systematic review of diffusion tensor imaging studies in affective disorders. Biol Psychiatry 2009; 66: 814-23.
63. Cullen KR, Klimes-Dougan B, Muetzel R, et al. Altered white matter microstructure in adolescents with major depression: a preliminary study. J Am Acad Child Adolesc Psychiatry 2009; 49: 173-83.
64. Yang Q, Huang XB, Hong N, Yu X. white matter microstructural abnormalities in late-life depression. Int Psychogeriatr 2007; 19: 757-66.
65. Abe O, Yamasue H, Kasai K, et al. Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression. Psychiatry Res 2009; 181: 64-70.
66. Zhu XL, Wang XA, Xiao J, Zhong MT, Liao JA, Yao SQ. Altered white matter integrity in first-episode, treatment-naive young adults with major depressive disorder: a tract-based spatial statistics study. Brain Res 2011; 1369: 223-9.
67. Kieseppa T, Eerola M, Mäntylä R, et al. Major depressive disorder and white matter abnormalities: a diffusion tensor imaging study with tract-based spatial statistics. J Affect Disord 2009; 120: 240-4.
68. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003; 65: 193-5.
69. Mayberg HS. Modulating limbic-cortical circuits in depression: targets of antidepressant treatments. Semin Clin Neuropsychiatry 2002; 7: 255-6.
70. Shah PJ, Glabus MF, Goodwin GM, Ebmeier KP. Chronic, treatment-resistant depression and right fronto-striatal atrophy. Br J Psychiatry 2002; 180: 434-40.
71. Furtado CP, Maller JJ, Fitzgerald PB. A magnetic resonance imaging study of the entorhinal cortex in treatment-resistant depression. Psychiatry Res 2008; 163: 133-42.
72. Zhang TJ, Wu QZ, Huang XQ, et al. Magnetization transfer imaging reveals the brain deficit in patients with treatment-refractory depression. J Affect Disord 2009; 117: 157-61.
73. Stein JF, Glickstein M. Role of the cerebellum in visual guidance of movement. Physiol Rev 1992; 72: 967-1017.
74. Stoodley CJ. The cerebellum and cognition: evidence from functional imaging studies. Cerebellum 2012; 11: 352-65.
75. Schmahmann JD. The role of the cerebellum in cognition and emotion: personal reflections since 1982 on the dysmetria of thought hypothesis, and its historical evolution from theory to therapy. Neuropsychol Rev 2010; 20: 236-60.
76. Vilensky JA, Van Hoesen GW. Corticopontine projections from the cingulate cortex in the rhesus monkey. Brain Res 1981; 205: 391-5.
77. Alexopoulos GS. Depression in the elderly. Lancet 2005; 365: 1961-70.
78. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 1997; 54: 915-22.
79. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and virchow-robin spaces. Am J Roentgenol 1988; 151: 551-8.
80. Hommel M, Gray F. Microvascular pathology. Berlin: Springer Verlag, 1995.
81. Zou K, Huang X, Li T, Gong, et al. Alterations of white matter integrity in adults with major depressive disorder: a magnetic resonance imaging study. J Psychiatry Neurosci 2008; 33: 525-30.
82. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006; 31: 1487-505.
83. Smith SM, Johansen-Berg H, Jenkinson M, et al. Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2007; 2: 499-503.
84. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000; 48: 813-29.
85. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception, I: the neural basis of normal emotion perception. Biol Psychiatry 2003; 54: 504-14.
86. Arnsten AF, Rubia K. Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry 2012; 51: 356-67.
87. Niciu MJ, Ionescu DF, Richards EM, Zarate CA Jr. Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm 2014; 121: 907-24.
88. Rigucci S, Serafini G, Pompili M, Kotzalidis GD, Tatarelli R. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. World J Biol Psychiatry 2010; 11: 165-80.
89. Savitz JB, Drevets WC. Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience 2009; 164: 300-30.